Department of Pathology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Clin Chest Med. 2011 Dec;32(4):669-92. doi: 10.1016/j.ccm.2011.08.005.
This article reviews current concepts in pathologic classification of lung cancer based on the 2004 World Health Organization classification of lung tumors and the 2011 International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification of lung adenocarcinoma. Preinvasive lesions are discussed. The major changes in lung disease diagnosis affected by the IASLC/ATS/ERS classification are presented. For adenocarcinomas diagnosed in small biopsies, specific terminology and diagnostic criteria are proposed along with recommendations for strategic management of tissue and EGFR mutation testing in patients with advanced adenocarcinoma. Histologic criteria are also presented for other tumors.
本文回顾了基于 2004 年世界卫生组织(WHO)肺部肿瘤分类和 2011 年国际肺癌研究协会(IASLC)/美国胸科学会(ATS)/欧洲呼吸学会(ERS)肺腺癌分类的肺癌病理分类的当前概念。讨论了癌前病变。介绍了 IASLC/ATS/ERS 分类影响肺部疾病诊断的主要变化。对于小活检中诊断的腺癌,提出了特定的术语和诊断标准,并就晚期腺癌患者的组织和 EGFR 突变检测的策略管理提出了建议。还提出了其他肿瘤的组织学标准。